Apellis Medical Hub Canada
  • Science
    • Geographic Atrophy
    • Pipeline
  • Medical Research
    • Scientific Focus
    • Investigator Initiated Trials
    • Collaborative Research
    • Medical Writing Grants
  • Congress &
    Manuscripts
    • Congress Presentations
    • Manuscripts
  • Resources
    • Medical Information
    • Compassionate Use Program
  • This website is intended only for use by Canadian Healthcare Professionals.


    CANADA


    Language


    EN | FR
  • Menu Menu
  • Science
    • Geographic Atrophy
    • Pipeline
  • Medical Research
    • Scientific Focus
    • Investigator Initiated Trials
    • Collaborative Research
    • Medical Writing Grants
  • Congress &
    Manuscripts
    • Congress Presentations
    • Manuscripts
  • Resources
    • Medical Information
    • Compassionate Use Program
  • This website is intended only for use by Canadian Healthcare Professionals.


    CANADA


    Language


    EN | FR

Our Scientific Focus

Apellis is dedicated to improving the lives of individuals living with serious disease driven by complement and supports medical and scientific research that demonstrates the highest level of scientific integrity, inclusion, and curiosity.

Ophthalmology
Geographic Atrophy (GA)

  • Long term (> 5yr) natural history data on geographic atrophy (GA) patients, including impact of progression on patients with low vision
  • Assessing structural changes in the retina during GA progression
  • Development of tests to evaluate visual function in patients with GA
  • Relationship between choroidal neovascularization (CNV) and the development of GA
  • Identification and validation of biomarkers of disease progression

Report an Adverse Event or Product complaint

Please call 833-866-3346

Ask a Medical Question

Please click here or email medinfo@apellis.com

Connect with an MSL

Set up a meeting with your
Medical Science Liaison

Privacy PolicyTerms and Conditions

©2023 Apellis Pharmaceuticals, Inc. All rights reserved. 07/23 MED-CA-PEGGA-23-00001 v2.0
Scroll to top
You are now leaving ApellisMedicalHub.ca

You are about to leave ApellisMedicalHub.ca to visit a third-party website. We recommend reviewing the privacy policy and terms & conditions of any site you visit, as Apellis Pharmaceuticals, Inc. is not responsible for their content.

I agree
Apellis Medical Affairs

Site Access

You must be a Healthcare Professional licensed to practice in Canada to access this site. Please fill in the form below to verify you are a Canadian Healthcare Professional.

"*" indicates required fields

You are entering a website that is technical in nature and was created for scientific exchange with Canadian Healthcare Professionals. The content on this website may include scientific information about investigational compounds or indications that are not approved in Canada. Apellis does not support, endorse or recommend the unapproved use of any compound, including those discussed on this website.

If you are a Canadian Healthcare Professional please submit the form below.

(*) Required
By submitting this form I certify that I am a Healthcare Professional licensed to practice in Canada and that the information provided during the registration process is accurate and current.


 

If you are not a Canadian Healthcare Professional, you will be redirected to www.apellis.ca

 

I’m a United States Healthcare Professional